Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Oculis establishes its US headquarters in Boston, MA, a world-renowned biotech hub, to support its continued expansion following OCS listing into NASDAQ Oculis’s finance and development team...
ZUG, Switzerland and BOSTON, April 05, 2023 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS) (“Oculis”), a global biopharmaceutical company purposefully driven to save sight and improve eye...
ZUG, Switzerland and BOSTON, April 04, 2023 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS) (“Oculis”), a global biopharmaceutical company purposefully driven to save sight and improve eye...
ZUG, Switzerland, and BOSTON, March 22, 2023 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS) (“Oculis”), a global biopharmaceutical company purposefully driven to save sight and improve eye...
Completed enrollment in Phase 3 OPTIMIZE trial brings OCS-01 one step further on the regulatory path to approval.If approved, OCS-01 has the potential to become the first once-daily, topical...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.4 | -2.29885057471 | 17.4 | 17.4 | 16.9 | 22663 | 17.01649465 | CS |
| 4 | 1.25 | 7.93650793651 | 15.75 | 17.92 | 15.4514 | 32648 | 16.89350332 | CS |
| 12 | 1.9 | 12.582781457 | 15.1 | 18 | 14 | 48452 | 16.14028504 | CS |
| 26 | 5.11 | 42.9772918419 | 11.89 | 18 | 10.79 | 35279 | 14.70813792 | CS |
| 52 | 5.7 | 50.4424778761 | 11.3 | 18 | 10.1 | 36096 | 13.38644916 | CS |
| 156 | 6.05 | 55.2511415525 | 10.95 | 18 | 6.26 | 29522 | 12.56176021 | CS |
| 260 | 6.05 | 55.2511415525 | 10.95 | 18 | 6.26 | 29522 | 12.56176021 | CS |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
